Moxibustion as an Adjuvant Therapy for Chronic Kidney Disease: A Systematic Review and Meta-Analysis of 23 Randomized Controlled Trials.

Yong FuQingni WuYanping WangQing RenWeifeng ZhuZiqian YaoJianrong Chen

Published in: Evidence-based complementary and alternative medicine : eCAM (2020)

This systematic review suggests that, as an adjuvant therapy, moxibustion may improve serum creatinine, urinary protein excretion, blood urea nitrogen, and quality of life in patients with CKD. Moxibustion may not have effects on eGFR, creatinine clearance, or hemoglobin. The quality of evidence is weakened by the limitations of risk of bias, heterogeneity, and imprecision.

Keyphrases

systematic review
chronic kidney disease
end stage renal disease
small cell lung cancer
uric acid
meta analyses
early stage
epidermal growth factor receptor
protein protein
amino acid
metabolic syndrome
randomized controlled trial
quality improvement
red blood cell